On Sept. 4, two South Carolina residents filed a proposed class-action lawsuit against Walgreens, alleging the retailer failed to warn customers about a carcinogenic ingredient in a common cold medicine.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
